Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applied Veterinary Genomics is a biotechnology company that specializes in the application of genomic science to improve canine health and wellness. Founded by Dr. Mark Neff, the company focuses on identifying genetic markers associated with hereditary diseases, behavioral traits, and breed composition in dogs. Its research utilizes genome-wide association studies (GWAS) to translate complex genetic data into practical diagnostic tools for veterinarians and pet owners. The company's intellectual property and expertise were eventually integrated into Wisdom Health, a division of Mars Petcare, where they continue to power leading commercial canine DNA tests. Applied Veterinary Genomics played a pivotal role in advancing the field of companion animal genetics and personalized veterinary medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applied Veterinary Genomics.